FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alison Galvani

Research Profile

Concepts & Ideas

Phenomena

Disease Outbreaks

Procedures

Disorders

Chemicals & Drugs

Influenza Vaccines

Activities & Behaviors

Geographic Areas

United States

Physiology

Biological Evolution

Co-author Network

Publications

TOP 3
Martial L Ndeffo Mbah; Evan W Orenstein; Eric M Poolman; Jeffrey Townsend; Katherine E Atkins; Eyrun F Kjetland; Lauren Ancel Meyers; Alison P Galvani
Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa.
Eunha Shim; Alison P Galvani
Distinguishing vaccine efficacy and effectiveness.
David P Durham; Yoko Ibuka; Eric M Poolman; Jeffrey P Townsend; Alison P Galvani
Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alison Galvani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martial L Ndeffo Mbah; Evan W Orenstein; Eric M Poolman; Jeffrey Townsend; Katherine E Atkins; Eyrun F Kjetland; Lauren Ancel Meyers; Alison P Galvani
Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(19):7952-7.
2012: Eunha Shim; Alison P Galvani
Distinguishing vaccine efficacy and effectiveness.
Vaccine 2012;30(47):6700-5.
2012: David P Durham; Yoko Ibuka; Eric M Poolman; Jeffrey P Townsend; Alison P Galvani
Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types.
The Journal of infectious diseases 2012;206(8):1291-8.
2012: Yoko Ibuka; A David Paltiel; Alison P Galvani
Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs.
Medical decision making : an international journal of the Society for Medical Decision Making 2012;32(3):442-6.
2012: Jennifer E Simpson; Theodore G Andreadis; Alison P Galvani; Paul J Hurtado; Jan Medlock; Goudarz Molaei; Maria A Diuk-Wasser
Vector host-feeding preferences drive transmission of multi-host pathogens: West Nile virus as a model system.
Proceedings. Biological sciences / The Royal Society 2012;279(1730):925-33.
2012: Jingzhou Liu; Yonas I Tekle; Beth F Kochin; Alison P Galvani
Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel.
Journal of the Royal Society, Interface / the Royal Society 2012;9(66):68-76.
2012: Yonas I Tekle; Alison P Galvani; Jingzhou Liu; Lauren A Meyers; Kaare M Nielsen; Melinda M Pettigrew; Jeffrey Townsend
Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains.
PloS one 2012;7(12):e50688.
2012: Meagan C Fitzpatrick; Katie Hampson; Lauren Ancel Meyers; Jeffrey P Townsend; Sarah Cleaveland; Alison P Galvani
Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania.
PLoS neglected tropical diseases 2012;6(8):e1796.
2012: Martial L Ndeffo Mbah; Yonas I Tekel; Chris T Bauch; Jingzhou Liu; Jan Medlock; Lauren Ancel Meyers; Alison P Galvani
The impact of imitation on vaccination behavior in social contact networks.
PLoS computational biology 2012;8(4):e1002469.
2011: Chad R Wells; Alison P Galvani; Lauren Ancel Meyers; Jean M Tchuenche; Chris T Bauch
Impact of imitation processes on the effectiveness of ring vaccination.
Bulletin of mathematical biology 2011;73(11):2748-72.
2011: Paula Mendes Luz; Tazio Vanni; Jan Medlock; A David Paltiel; Alison P Galvani
Dengue vector control strategies in an urban setting: an economic modelling assessment.
Lancet 2011;377(9778):1673-80.
2011: Timothy C Reluga; Alison P Galvani
A general approach for population games with application to vaccination.
Mathematical biosciences 2011;230(2):67-78.
2011: Daniel M Cornforth; Timothy C Reluga; Eunha Shim; Chris T Bauch; Alison P Galvani; Lauren Ancel Meyers
Erratic flu vaccination emerges from short-sighted behavior in contact networks.
PLoS computational biology 2011;7(1):e1001062.
2010: Eunha Shim; Gretchen B Chapman; Alison P Galvani
Decision making with regard to antiviral intervention during an influenza pandemic.
Medical decision making : an international journal of the Society for Medical Decision Making 2010;30(4):E64-81.
2010: Chris T Bauch; Meng Li; Gretchen Chapman; Alison P Galvani
Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?
The Lancet infectious diseases 2010;10(2):133-7.
2010: Paula M Luz; Claudio J Struchiner; Alison P Galvani
Modeling transmission dynamics and control of vector-borne neglected tropical diseases.
PLoS neglected tropical diseases 2010;4(10):e761.
2010: Yoko Ibuka; Gretchen B Chapman; Lauren A Meyers; Meng Li; Alison P Galvani
The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza.
BMC infectious diseases 2010;10():296.
2009: Eunha Shim; Katie Hampson; Sarah Cleaveland; Alison P Galvani
Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania.
Vaccine 2009;27(51):7167-72.
2009: Eunha Shim; Beth Kochin; Alison P Galvani
Insights from epidemiological game theory into gender-specific vaccination against rubella.
Mathematical biosciences and engineering : MBE 2009;6(4):839-54.
2009: Jan Medlock; Paula M Luz; Claudio J Struchiner; Alison P Galvani
The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes.
The American naturalist 2009;174(4):565-77.
2009: Jan Medlock; Alison P Galvani
Optimizing influenza vaccine distribution.
Science (New York, N.Y.) 2009;325(5948):1705-8.
2009: P M Luz; C T Codeço; Jan Medlock; C J Struchiner; D Valle; Alison P Galvani
Impact of insecticide interventions on the abundance and resistance profile of Aedes aegypti.
Epidemiology and infection 2009;137(8):1203-15.
2009: Sanjay Basu; Alison P Galvani
The evolution of tuberculosis virulence.
Bulletin of mathematical biology 2009;71(5):1073-88.
2009: Eunha Shim; Alison P Galvani
Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
Vaccine 2009;27(30):4025-30.
2009: Evan W Orenstein; Sanjay Basu; Sarita Shah; Jason R Andrews; Gerald H Friedland; Anthony P Moll; Neel Gandhi; Alison P Galvani
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
The Lancet infectious diseases 2009;9(3):153-61.
2009: P M Luz; B Grinsztejn; Alison P Galvani
Disability adjusted life years lost to dengue in Brazil.
Tropical medicine & international health : TM & IH 2009;14(2):237-46.
2009: Eunha Shim; Alison P Galvani
Evolutionary repercussions of avian culling on host resistance and influenza virulence.
PloS one 2009;4(5):e5503.
2008: Sanjay Basu; Gretchen B Chapman; Alison P Galvani
Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(48):19018-23.
2008: Paula M Luz; Beatriz V M Mendes; Claudia T Codeço; Claudio J Struchiner; Alison P Galvani
Time series analysis of dengue incidence in Rio de Janeiro, Brazil.
The American journal of tropical medicine and hygiene 2008;79(6):933-9.
2008: Sanjay Basu; Alison P Galvani
The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.
Epidemiology and infection 2008;136(12):1585-98.
2008: Sanjay Basu; Evan Orenstein; Alison P Galvani
The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics.
The Journal of infectious diseases 2008;198(10):1502-13.
2008: Eric M Poolman; Elamin H Elbasha; Alison P Galvani
Vaccination and the evolutionary ecology of human papillomavirus.
Vaccine 2008;26 Suppl 3():C25-30.
2008: Changyun Hu; Rita V M Rio; Jan Medlock; Lee R Haines; Dana Nayduch; Amy F Savage; Nurper Guz; Geoffrey Attardo; Terry W Pearson; Alison P Galvani; Serap Aksoy
Infections with immunogenic trypanosomes reduce tsetse reproductive fitness: potential impact of different parasite strains on vector population structure.
PLoS neglected tropical diseases 2008;2(3):e192.
2007: Timothy C Reluga; R Meza; D B Walton; Alison P Galvani
Reservoir interactions and disease emergence.
Theoretical population biology 2007;72(3):400-8.
2007: Timothy C Reluga; Jan Medlock; Eric M Poolman; Alison P Galvani
Optimal timing of disease transmission in an age-structured population.
Bulletin of mathematical biology 2007;69(8):2711-22.
2007: Sanjay Basu; Jason R Andrews; Eric M Poolman; Neel Gandhi; Sarita Shah; Anthony Moll; Prashini Moodley; Alison P Galvani; Gerald Friedland
Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.
Lancet 2007;370(9597):1500-7.
2007: Alison P Galvani; Timothy C Reluga; Gretchen B Chapman
Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(13):5692-7.
2007: Eric M Poolman; Alison P Galvani
Evaluating candidate agents of selective pressure for cystic fibrosis.
Journal of the Royal Society, Interface / the Royal Society 2007;4(12):91-8.
2006: Timothy C Reluga; Chris T Bauch; Alison P Galvani
Evolving public perceptions and stability in vaccine uptake.
Mathematical biosciences 2006;204(2):185-98.
2006: Eric M Poolman; Alison P Galvani
Modeling targeted ivermectin treatment for controlling river blindness.
The American journal of tropical medicine and hygiene 2006;75(5):921-7.
2006: Alison P Galvani; Jan Medlock; Gretchen B Chapman
The ethics of influenza vaccination.
Science (New York, N.Y.) 2006;313(5788):758-60; author reply 758-60.
2006: Timothy C Reluga; Jan Medlock; Alison P Galvani
A model of spatial epidemic spread when individuals move within overlapping home ranges.
Bulletin of mathematical biology 2006;68(2):401-16.
2005: Chris T Bauch; James O Lloyd-Smith; Megan P Coffee; Alison P Galvani
Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future.
Epidemiology (Cambridge, Mass.) 2005;16(6):791-801.
2005: John Novembre; Alison P Galvani; Montgomery Slatkin
The geographic spread of the CCR5 Delta32 HIV-resistance allele.
PLoS biology 2005;3(11):e339.
2005: Alison P Galvani
The role of mutation accumulation in HIV progression.
Proceedings. Biological sciences / The Royal Society 2005;272(1574):1851-8.
2005: Travis C Porco; James O Lloyd-Smith; Kimber L Gross; Alison P Galvani
The effect of treatment on pathogen virulence.
Journal of theoretical biology 2005;233(1):91-102.
2005: Alison P Galvani
Age-dependent epidemiological patterns and strain diversity in helminth parasites.
The Journal of parasitology 2005;91(1):24-30.
2005: Alison P Galvani; John Novembre
The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
Microbes and infection / Institut Pasteur 2005;7(2):302-9.
2004: Alison P Galvani
Emerging infections: what have we learned from SARS?
Emerging infectious diseases 2004;10(7):1351-2.
2004: Alison P Galvani; Montgomery Slatkin
Intense selection in an age-structured population.
Proceedings. Biological sciences / The Royal Society 2004;271(1535):171-6.
2003: Alison P Galvani; Montgomery Slatkin
Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):15276-9.
2003: James O Lloyd-Smith; Alison P Galvani; Wayne M Getz
Curtailing transmission of severe acute respiratory syndrome within a community and its hospital.
Proceedings. Biological sciences / The Royal Society 2003;270(1528):1979-89.
2003: Chris T Bauch; Alison P Galvani; David J D Earn
Group interest versus self-interest in smallpox vaccination policy.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(18):10564-7.
2003: Alison P Galvani; Lei Xiudong; Nicholas P Jewell
Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times.
Emerging infectious diseases 2003;9(8):991-4.
2003: Chris T Bauch; Alison P Galvani
Using network models to approximate spatial point-process models.
Mathematical biosciences 2003;184(1):101-14.
2003: Alison P Galvani
Immunity, antigenic heterogeneity, and aggregation of helminth parasites.
The Journal of parasitology 2003;89(2):232-41.
2003: Alison P Galvani; Ronald M Coleman; Neil M Ferguson
The maintenance of sex in parasites.
Proceedings. Biological sciences / The Royal Society 2003;270(1510):19-28.